A Risk-Benefit Assessment of Serotonin 5-HT Receptor Antagonists in Antineoplastic Therapy-Induced Emesis

ISSN： 0114-5916

Source： Drug Safety, Vol.18, Iss.1, 1998-01, pp. : 43-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stratified Administration of Serotonin 5-HT Receptor Antagonists (Setrons) for Chemotherapy-Induced Emesis: Economic Implications

By Sanchez L.A.

PharmacoEconomics, Vol. 18, Iss. 6, 2000-12 ,pp. : 533-556

Adis International

Access to resources Recommend Favorite

Risk-benefit assessment of angiotensin II receptor antagonists

By Shusterman Neil

Expert Opinion on Drug Safety, Vol. 1, Iss. 2, 2002-07 ,pp. : 137-152

Informa Healthcare

Access to resources Recommend Favorite

Action of 5-HT 3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew)

By Sam T.S.W. Cheng J.T.Y. Johnston K.D. Kan K.K.W. Ngan M.P. Rudd J.A. Wai M.K. Yeung J.H.K.

European Journal of Pharmacology, Vol. 472, Iss. 1, 2003-07 ,pp. : 135-145

Elsevier

Access to resources Recommend Favorite

Serotonin 5-HT7 Receptor Antagonists

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 3, 2004-09 ,pp. : 203-214

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of 5-HT 1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex

By Dawson L.A. Nguyen H.Q.

European Journal of Pharmacology, Vol. 345, Iss. 1, 1998-03 ,pp. : 41-46

Elsevier

Access to resources Recommend Favorite